insitro Stock
Insitro operates as a drug discovery and development company that leverages machine learning and high-throughput biology.
Sign up for SecondMarket™ to view the market and buy or sell insitro Stock
Buy + Sellinsitro Funding
Sign up to gain insights into insitro funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the DataDate | Financing Round | Amount | Price per share* | Valuation* |
---|---|---|---|---|
Apr 07, 2021 | Series C | 400.00M | ||
Mar 26, 2020 | Series B | 143.21M | ||
Apr 16, 2019 | Series A | 49.41M | ||
Apr 16, 2019 | Series A | 30.00M |
See insitro Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into insitro Stock Valuation + Share Prices
View real-time Tape D™ data on insitro stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Startedinsitro Management Team
CFO
Mary Rozeman
Founder, CEO, Director
Daphne Koller
Director
Robert Nelsen
Chief Technology Officer
Ajamete Kaykas
Director
Vijay Pande
insitro Major Investors
T. Rowe Price Associates, Inc.
Andreessen Horowitz LLC; AKA: A16Z
Foresite Capital
HOF Capital
Mubadala Investment Company
Alexandria Venture Investments
Canada Pension Plan Investment Board (CPPIB)
Casdin Capital
BlackRock Inc
ARCH Venture Partners
Two Sigma Ventures
WuXi AppTec
Third Rock Ventures LLC
Google Ventures (GV)
Temasek Holdings Pte, Ltd.
Temasek Holdings Pte, Ltd.